title: Gene-panel sequencing and the prediction of breast-cancer risk.
authors.affiliation: From the Departments of Public Health and Primary Care (D.F.E., P.D.P.P., A.C.A.), Oncology (D.F.E., P.D.P.P.), and Medical Genetics (M.T.), University of Cambridge, Cambridge, the Centre for Genomic Medicine, Institute of Human Development, Manchester Academic Health Science Centre, University of Manchester and St. Mary's Hospital, Manchester (D.G.R.E.), and the Division of Genetics and Epidemiology, Institute of Cancer Research, London (N.R.) - all in the United Kingdom; the Departments of Oncological Sciences (S.V.T.) and Dermatology (D.E.G.), Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City; the Basser Research Center for BRCA and Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia (K.L.N., S.M.D.); the Department of Human Genetics and Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands (P.D.); the Department of Obstetrics and Gynecology, Division of Tumor Genetics, Klinikum rechts der Isar, Technische Universität München, Munich, Germany (A.M.); the Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (F.J.C.); the Department of Pathology, School of Biomedical Sciences, Faculty of Medicine, Dentistry, and Health Sciences at the University of Melbourne, Parkville, VIC (M.S.), and the QIMR Berghofer Medical Research Institute, Herston, QLD (G.C.-T.) - both in Australia; the Clinical Genetics Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York (M.R.); and the Program in Cancer Genetics, Departments of Human Genetics and Oncology, the Lady Davis Institute for Medical Research, and the Research Institute of the McGill University Health Center, McGill University, Montreal (W.D.F.).
authors.forename: Douglas F
authors.initials: DF
authors.lastname: Easton
authors.forename: Paul D P
authors.initials: PD
authors.lastname: Pharoah
authors.forename: Antonis C
authors.initials: AC
authors.lastname: Antoniou
authors.forename: Marc
authors.initials: M
authors.lastname: Tischkowitz
authors.forename: Sean V
authors.initials: SV
authors.lastname: Tavtigian
authors.forename: Katherine L
authors.initials: KL
authors.lastname: Nathanson
authors.forename: Peter
authors.initials: P
authors.lastname: Devilee
authors.forename: Alfons
authors.initials: A
authors.lastname: Meindl
authors.forename: Fergus J
authors.initials: FJ
authors.lastname: Couch
authors.forename: Melissa
authors.initials: M
authors.lastname: Southey
authors.forename: David E
authors.initials: DE
authors.lastname: Goldgar
authors.forename: D Gareth R
authors.initials: DG
authors.lastname: Evans
authors.forename: Georgia
authors.initials: G
authors.lastname: Chenevix-Trench
authors.forename: Nazneen
authors.initials: N
authors.lastname: Rahman
authors.forename: Mark
authors.initials: M
authors.lastname: Robson
authors.forename: Susan M
authors.initials: SM
authors.lastname: Domchek
authors.forename: William D
authors.initials: WD
authors.lastname: Foulkes
mesh_terms: D001943:Breast Neoplasms / Q000175:diagnosis / Q000235:genetics*; D002487:Centers for Disease Control and Prevention, U.S.; D005260:Female; D019398:Genes, BRCA1; D024522:Genes, BRCA2; D020022:Genetic Predisposition to Disease; D005820:Genetic Testing / Q000592:standards*; D014644:Genetic Variation; D060005:Genotyping Techniques; D017408:Guidelines as Topic; D006579:Heterozygote; D006801:Humans; D012306:Risk; D017422:Sequence Analysis, DNA; D014481:United States